Showing results (691-700 of 1,929) with videos related to
Sort By:
Pageof 193
Hospital Pharmacy|September 2, 2025
Evaluating the Effectiveness of Risk Categories for Prioritising Patients for Best Possible Medication History Completion at a Quaternary HospitalMarissa Ryan, Jane Dunsdon, Karl Winckel, et al.Hospital Pharmacy|September 14, 2016
Ranolazine-Induced Reversible T-Wave Inversions with Prolonged QTc Interval; Progressive Multifocal Leukoencephalopathy Linked to Fingolimod; Losartan-Induced Sprue-like Enteropathy; Nivolumab-Induced Psoriasiform Skin Eruption; Hepatitis B Reactivation with Hepatitis C Treatment with Simeprevir and SofosbuvirMichael A MancanoHospital Pharmacy|September 14, 2016
Sacubitril/ValsartanDennis J Cada, Danial E Baker, James LeonardHospital Pharmacy|September 14, 2016
Exploring the ONC's Health IT DashboardBrent I Fox, Bill G FelkeyHospital Pharmacy|July 25, 2018
Utilization of Lean Techniques in Pharmacy Residency Training: Modifying the PGY1 Management and Leadership ExperienceKaren J Arthur, Deanna S Kania, Christina A WhiteHospital Pharmacy|May 19, 2017
Implementing a Tech-Check-Tech Program at a University Health SystemScott A Tarver, Javier Palacios, Reed Hall, et al.Hospital Pharmacy|May 19, 2017
Evaluating Sterility of Single Dose Vials on an Automated Compounding DeviceHannah M Hutchinson, Brian E Sayre, Terrence Prettyman, et al.Hospital Pharmacy|May 19, 2017
Anti-Nuclear Cytoplasmic Antibody-Associated Vasculitis: A Probable Adverse Effect of Sofosbuvir Treatment in Chronic Hepatitis C PatientsYoussef K Ahmad, Salwa Tawfeek, Mohamed Sharaf-Eldin, et al.Hospital Pharmacy|April 26, 2017
Compliance with Updated Sepsis Bundles to Meet New Sepsis Core Measure in a Tertiary Care HospitalTaylor H Ramsdell, April N Smith, Eric KerkhoveHospital Pharmacy|April 26, 2017
Clinical Feasibility of Monitoring Enoxaparin Anti-Xa Concentrations: Are We Getting It Right?Wesley D Kufel, Robert W Seabury, William Darko, et al.Pageof 193